BioCatch Funding: $300M Raised, Series D (2023)

BioCatch funding overview

BioCatch is based in Tel Aviv, Israel. BioCatch has raised $300M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series D announced in November 2023. The round record for BioCatch runs through 2023; nothing later has been disclosed. Investors on record include Sapphire Ventures, Bain Capital Tech Opportunities, Maverick Ventures, American Express Ventures, Goldman Sachs, Citi Bank and 5 others. 11 distinct backers are named across the disclosed rounds.

BioCatch at a glance

Total raised: $300M
Latest round: Series D
Latest round date: November 2023
Headquarters: Tel Aviv, Israel
Notable investors: Sapphire Ventures, Bain Capital Tech Opportunities, Maverick Ventures, American Express Ventures, Goldman Sachs, Citi Bank, Barclays, HSBC

Frequently asked about BioCatch funding

How much has BioCatch raised?: BioCatch has raised $300M in total disclosed funding across the rounds on record.
Who has invested in BioCatch?: Sapphire Ventures, Bain Capital Tech Opportunities, Maverick Ventures, American Express Ventures, Goldman Sachs, Citi Bank are named among the investors backing BioCatch.
What was the latest BioCatch funding round?: The most recent disclosed round is a Series D, announced in November 2023.
Where is BioCatch based?: BioCatch is based in Tel Aviv, Israel.
When did BioCatch last raise?: The last disclosed BioCatch round closed in November 2023 at Series D.

Every BioCatch figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Tel Aviv at a similar stage.

BioCatch Funding: $300M Raised, Series D (2023)

BioCatch funding overview

BioCatch at a glance

Frequently asked about BioCatch funding

Companies related to BioCatch (36)

Browse related funding lists (9)